Possible Involvement of Muscarinic Receptor Blockade in Mirabegron Therapy for Patients with Overactive Bladder

Effect of (R)-2-(2-Aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} Acetanilide (YM178), a Novel Selective β3-Adrenoceptor Agonist, on Bladder Function

Toshiyuki Takasu, Masashi Ukai, Shuichi Sato et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 307 citations

Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins.

P Wang, G R Luthin, Michael R. Ruggieri · Journal of Pharmacology and Experimental Therapeutics · 1995 · 274 citations

A Quantitative Analysis of mRNA Expression of α1 and β-adrenoceptor Subtypes and Their Functional Roles in Human Normal and Obstructed Bladders

Masanori Nomiya, Osamu Yamaguchi · The Journal of Urology · 2003 · 234 citations

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder ( <scp>SYNERGY</scp> study)

Sender Herschorn, Christopher R. Chapple, Paul Abrams et al. · British Journal of Urology · 2017 · 171 citations · Full text

EXPRESSION AND POSSIBLE FUNCTIONAL ROLE OF THE beta 3-ADRENOCEPTOR IN HUMAN AND RAT DETRUSOR MUSCLE

Takao Fujimura, Kouichi Tamura, Takeshi Tsutsumi et al. · The Journal of Urology · 1999 · 162 citations